MYRIAD GENETICS INC - MYGN

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$571.4M

QoQ value delta ($000)

+$3.209M (+0.56%)

Implied price effect (QoQ)

-58.1%

Total shares

221,513,080

QoQ shares delta

+129,226,577 (+140.03%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 203 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ORBIMED ADVISORS LLC	122,875	125,000,000	2.44%
VANGUARD GROUP INC	50,586	8,225,371	0.0%
BlackRock, Inc.	40,003	8,889,644	0.0%
MILLENNIUM MANAGEMENT LLC	30,009	6,668,817	0.01%
GLENVIEW CAPITAL MANAGEMENT, LLC	24,353	5,411,978	0.61%
D. E. Shaw & Co., Inc.	20,248	4,499,724	0.01%
STATE STREET CORP	19,908	4,424,027	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	17,660	3,924,525	0.0%
MORGAN STANLEY	14,259	3,168,742	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	11,620	2,582,231	0.0%
GOLDMAN SACHS GROUP INC	10,647	2,366,092	0.0%
GEODE CAPITAL MANAGEMENT, LLC	10,439	2,319,379	0.0%
ACADIAN ASSET MANAGEMENT LLC	10,378	2,308,589	0.01%
JACOBS LEVY EQUITY MANAGEMENT, INC	9,398	2,088,492	0.04%
FEDERATED HERMES, INC.	8,892	1,976,166	0.01%
AQR CAPITAL MANAGEMENT LLC	8,605	1,912,296	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	8,106	1,801,478	0.0%
HRT FINANCIAL LP	8,038	1,786,319	0.02%
Qube Research & Technologies Ltd	7,607	1,690,461	0.01%
Vestal Point Capital, LP	7,416	1,648,000	0.21%
Assenagon Asset Management S.A.	6,511	1,446,961	0.01%
Connor, Clark & Lunn Investment Management Ltd.	5,933	1,318,663	0.01%
TWO SIGMA INVESTMENTS, LP	5,778	1,284,050	0.0%
JANE STREET GROUP, LLC	5,411	1,202,531	0.0%
Fisher Asset Management, LLC	5,359	1,190,896	0.0%